杉本 真也

Medicine & Life Sciences

1. Ulcerative Colitis 100%
2. Organoids 69%
3. Indigo Carmine 29%
4. Colonoscopy 26%
5. Colon 22%
6. Infliximab 14%
7. Stomach Neoplasms 14%
8. Stem Cells 14%
9. Mesalamine 13%
10. Crohn Disease 12%
11. Fecal Microbiota Transplantation 12%
12. Coronavirus Infections 12%
13. Sigmoid Colon 12%
14. Immersion 11%
15. Intestinal Mucosa 11%
16. Water 11%
17. Neoplasms 11%
18. Severe Acute Respiratory Syndrome 10%
19. Colitis 10%
20. Qingdai compound 10%
21. Therapeutics 10%
22. Recurrence 10%
23. Signet Ring Cell Carcinoma 10%
24. Inflammatory Bowel Diseases 10%
25. Japan 9%
26. Mucous Membrane 9%
27. Coronavirus 8%
28. Heterologous Transplantation 8%
29. Epithelium 8%
30. N-acetyl-5-aminosalicylic acid 8%
31. Carcinogenesis 7%
32. Intestinal Volvulus 7%
33. Gastrointestinal Microbiome 7%
34. Stem Cell Niche 6%
35. Immunologic Factors 6%
36. Short Bowel Syndrome 6%
37. Irritable Bowel Syndrome 6%
38. Ustekinumab 6%
39. Calcineurin Inhibitors 6%
40. Randomized Controlled Trials 6%
41. Single-Domain Antibodies 6%
42. Stomach 6%
43. Color 6%
44. Intestinal Diseases 6%
45. Genotype 5%
46. Mutation 5%
47. Appendix 5%
48. Legionella 5%
49. Suppositories 5%